EICHOR
● Recruiting
A Study of SKB571 in Participants With Gastrointestinal Tumors
Condition: Gastrointestinal Tumors · Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
About this study
This is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability and preliminary anti-tumor activity of SKB571 in participants with gastrointestinal tumors.
This description comes directly from the study's public registry record.
Talk to the study team
Xin Li, MD · 86-13311373861 · lixin@kelun.com
Always discuss trial participation with your own doctor first.
Locations (25)
| Chongqing University Three Gorges Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
| Fujian Cancer Hospital | Fuzhou, Fujian, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Recruiting |
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| The Sixth Affiliated Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The People's Hospital of Guangxi Zhuang Autonomous Region | Nanning, Guangxi, China | Recruiting |
| The Fourth Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| Tumor Hospital of Harbin Medical University | Harbin, Heilongjiang, China | Not Yet Recruiting |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Recruiting |
| Hunan Cancer Hospital | Changsha, Hunan, China | Recruiting |
+ 13 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07564466